Our Products

Lapatinib Tablets 250 mg is a targeted therapy medication used to treat certain types of cancer, primarily HER2-positive breast cancer. It works by inhibiting the activity of two key proteins involved in cancer cell growth: epidermal growth factor receptor (EGFR) and HER2 (human epidermal growth factor receptor 2). By blocking these receptors, Lapatinib helps to slow or stop the growth and spread of cancer cells.

The typical dosage of Lapatinib 250 mg is usually taken once daily or as directed by a healthcare provider, often in combination with other chemotherapy drugs or treatments. Common side effects may include diarrhea, rash, nausea, fatigue, and liver enzyme changes. Regular monitoring of liver function and overall health is important during treatment to manage any potential side effects effectively.